Dolby Laboratories, Inc.
DLB- Exchange
- NYSE
- Industry
- Patent Owners & Lessors
- SEC CIK
- 0001308547
In the last 90 days, Dolby Laboratories, Inc. insiders filed 0 open-market purchases and 4 sales; 394 institutions reported holding it in 13F filings for Q2 2026, worth $3.25B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:46 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 26, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Sep 24, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 18, 2025 | Nov 19, 2024 | Nov 16, 2023 | Nov 17, 2022 | Nov 16, 2021 |
| Revenue | $1.35B | $1.27B | $1.30B | $1.25B | $1.28B |
| Cost of revenue | $160.1M | $140.5M | $152.6M | $141.4M | $130.0M |
| Gross profit | $1.19B | $1.13B | $1.15B | $1.11B | $1.15B |
| Operating expenses | $924.0M | $874.9M | $931.4M | $905.8M | $806.8M |
| Research and development | $261.8M | $263.7M | $271.5M | $261.2M | $253.6M |
| Selling, general and administrative | $286.5M | $270.4M | $258.5M | $275.3M | $224.2M |
| Operating income | $265.0M | $258.3M | $215.8M | $206.6M | $344.4M |
| Interest expense | – | – | – | $394.0K | $479.0K |
| Income tax | $47.0M | $48.2M | $48.4M | $31.4M | $36.7M |
| Net income | $255.0M | $261.8M | $200.7M | $184.1M | $310.2M |
| EPS, basic | $2.66 | $2.74 | $2.10 | $1.84 | $3.07 |
| EPS, diluted | $2.62 | $2.69 | $2.05 | $1.81 | $2.97 |
| Weighted shares, basic | 95.9M | 95.5M | 95.8M | 100.0M | 101.2M |
| Weighted shares, diluted | 97.5M | 97.3M | 97.7M | 102.0M | 104.6M |
| Margins and growth | |||||
| Gross margin | 88.1% | 89.0% | 88.3% | 88.7% | 89.9% |
| Operating margin | 19.6% | 20.3% | 16.6% | 16.5% | 26.9% |
| Net margin | 18.9% | 20.6% | 15.4% | 14.7% | 24.2% |
| Revenue growth, year over year | +5.9% | −2.0% | +3.7% | −2.1% | +10.3% |
| Net income growth, year over year | −2.6% | +30.5% | +9.0% | −40.7% | +34.1% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 26, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Sep 24, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 18, 2025 | Nov 19, 2024 | Nov 16, 2023 | Nov 17, 2022 | Nov 16, 2021 |
| Cash and equivalents | $701.9M | $482.0M | $745.4M | $620.1M | $1.23B |
| Short-term investments | $703.0K | $0 | $139.1M | $189.2M | $38.8M |
| Accounts receivable | $331.1M | $315.5M | $262.2M | $243.6M | $232.6M |
| Inventory | $30.4M | $33.7M | $35.6M | $23.5M | $11.0M |
| Total current assets | $1.39B | $1.19B | $1.49B | $1.31B | $1.76B |
| Property, plant and equipment | $470.6M | $479.1M | $481.6M | $513.5M | $534.4M |
| Goodwill | $529.9M | $533.2M | $408.4M | $365.1M | $340.7M |
| Intangible assets | $397.1M | $434.5M | $167.4M | $112.3M | $122.9M |
| Total assets | $3.23B | $3.11B | $2.98B | $2.69B | $3.11B |
| Accounts payable | $17.8M | $17.4M | $20.9M | $14.2M | $17.8M |
| Total current liabilities | $437.8M | $417.8M | $422.2M | $277.5M | $315.7M |
| Total liabilities | $595.8M | $623.0M | $607.6M | $438.5M | $501.5M |
| Shareholders' equity | $2.63B | $2.49B | $2.37B | $2.25B | $2.60B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Sep 26, 2025 | Sep 27, 2024 | Sep 29, 2023 | Sep 30, 2022 | Sep 24, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Nov 18, 2025 | Nov 19, 2024 | Nov 16, 2023 | Nov 17, 2022 | Nov 16, 2021 |
| Operating cash flow | $472.2M | $327.3M | $367.1M | $318.6M | $447.8M |
| Capital expenditures | $36.3M | $30.0M | $30.3M | $47.9M | $54.5M |
| Free cash flow | $435.9M | $297.2M | $336.7M | $270.6M | $393.3M |
| Depreciation and amortization | $87.8M | $75.6M | $82.6M | $88.5M | $95.9M |
| Stock-based compensation | $128.5M | $119.8M | $118.5M | $114.9M | $99.7M |
| Dividends paid | $126.6M | $114.6M | $103.4M | $100.1M | $89.2M |
| Share buybacks | $125.0M | $160.0M | $149.3M | $530.5M | $245.9M |
| Investing cash flow | -$10.6M | -$286.3M | $54.2M | -$295.9M | -$44.9M |
| Financing cash flow | -$247.2M | -$287.8M | -$236.8M | -$610.6M | -$252.5M |
| Net change in cash | $215.6M | -$240.2M | $189.6M | -$604.7M | $153.1M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 9.5% | 9.4% | 9.1% | 9.2% | 7.8% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Dolby Laboratories, Inc. reports no single share count on its 10-K and 10-Q covers. Companies with several share classes report one count per class, which this data doesn't include.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.